Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$101,270,001
+$96,918,027 QoQ
Shares Held
402,440
+1911.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#253
of 4,176 holders
Holding Since
Sep 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$95,623,200
PutShares
380,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. ABBV ranks #3 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
|
435,361 | $3,082,355 |
All Filings in ABBV
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,623,200 | 380,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $101,270,001 | 402,440 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,351,974 | 20,010 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $16,057,761 | 69,352 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $1,169,406 | 6,300 | Call | Sole | 2025-08-18 | |
| 2025-06-30 | $19,635,997 | 105,786 | Shares | Sole | 2025-08-18 | |
| 2025-06-30 | $10,431,844 | 56,200 | Put | Sole | 2025-08-18 | |
| 2025-03-31 | $147,481,128 | 703,900 | Put | Sole | 2025-05-14 | |
| 2025-03-31 | $136,370,491 | 650,871 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $13,618,800 | 65,000 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $4,975,600 | 28,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $5,349,303 | 30,103 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $25,593,408 | 129,600 | Call | Sole | 2024-11-13 | |
| 2024-09-30 | $14,811,000 | 75,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,145,600 | 30,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,420,000 | 200,000 | Put | Sole | 2024-05-15 | |
| 2023-09-30 | $31,384,881 | 210,552 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,535,270 | 330,552 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,211,960 | 108,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,201,860 | 26,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $26,842,000 | 200,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||